GRAIL, Inc. (GRALV)
Grail develops a pan-cancer screening test designed to detect cancers at an early stage. Its pan-cancer screening test measures circulating nucleic acids in blood using high-intensity sequencing, population-scale clinical trials, enabling doctors to develop blood tests for early-stage cancer detection. The company was founded in 2016 by Alex Aravanis and Jeff Huber in Menlo Park, California.
Address
1525 O'BRIEN DRIVE
MENLO PARK, CA 94025
Founded
2015
Number of Employees
-
Website
http://www.grail.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)